Dialysis After Contrast-Induced Nephropathy

Indications for Dialysis in CIN

Dialysis should be initiated emergently when patients develop life-threatening complications such as severe hyperkalemia, metabolic acidosis, volume overload with pulmonary edema, or uremic encephalopathy 1
The decision to start renal replacement therapy should consider the broader clinical context and trends of laboratory tests rather than single BUN and creatinine thresholds alone 1
Prophylactic hemodialysis or hemofiltration is not recommended for contrast media removal and prevention of CIN, as evidence shows absence of benefit and potential harm 1

Patients with chronic kidney disease (CKD), especially those with GFR <40 mL/min/1.73m², are at highest risk for developing CIN 2
CIN occurs in up to 15% of patients with chronic renal dysfunction undergoing radiographic procedures 3
Between 0.5-12% of patients with CIN require hemodialysis and experience prolonged hospitalization 3

Intravenous hydration with isotonic saline (0.9% NaCl) is the cornerstone of prevention, administered at 1 mL/kg/hour for 12 hours before and after the procedure 2, 4
Sodium bicarbonate (1.26%) may be used as an alternative to normal saline, especially for urgent procedures as it requires only one hour of pre-treatment 4
Use low-osmolar or iso-osmolar contrast media in the lowest possible dose for high-risk patients 1, 2
The volume of contrast media should be minimized to reduce risk of CIN 4, 2
Short-term high-dose statin therapy should be considered for prevention 4, 2

For patients with severe CKD (stage 4 or 5), prophylactic hemofiltration may be considered before complex interventions or high-risk surgery 4

In patients with stage 3 CKD, prophylactic hemodialysis is specifically not recommended 4
Meta-analyses of clinical trials have demonstrated an absence of benefit and potential risk of harm with prophylactic hemodialysis 1
Contrast removal via extracorporeal therapies is unlikely to prevent kidney damage, which develops within minutes of contrast administration 1

Discontinue renal replacement therapy when intrinsic kidney function has recovered to the point that it is adequate to meet patient needs 1
Persistent worsening of renal function (>10% decrease compared with baseline) after contrast exposure is associated with significantly higher mortality (HR 7.3) 3